EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women

Natalia Briceño-Patiño, María Camila Prieto, Paula Manrique, Carlos-Alberto Calderon-Ospina iD, Leonardo Gómez

Pharmaceutics · 15.07.2025 · 17 (7) · 913

DOI: 10.3390/pharmaceutics17070913 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 15.07.2025. Verfasst von Natalia Briceño-Patiño und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitario Mayor—Méderi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnancy introduces significant physiological changes that alter the pharmacokinetics (PK) of antiretroviral therapy (ART), impacting its safety and efficacy in HIV-positive women. Optimizing ART during pregnancy is critical to maintaining maternal virological suppression and preventing mother-to-child transmission (MTCT) of HIV. This review evaluates the impact of pregnancy-induced PK changes on ART and proposes strategies for tailored regimens to improve outcomes. A comprehensive review of published literature was conducted, focusing on PK adaptations during pregnancy and their implications for different ART classes, including protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and nucleoside reverse transcriptase inhibitors (NRTIs). Key studies were analyzed to assess drug exposure, efficacy, and safety. Pregnancy significantly alters the PK of antiretrovirals, with increased hepatic metabolism, renal clearance, and changes in plasma protein binding leading to reduced drug exposure. For example, drugs like lopinavir and atazanavir require dose adjustments, while dolutegravir maintains efficacy despite reduced plasma levels. Integrase inhibitors demonstrate favorable virological suppression, although cobicistat-boosted regimens show subtherapeutic levels. Tailored approaches, such as therapeutic drug monitoring (TDM), optimize ART efficacy while minimizing toxicity. Pregnancy-specific PK changes necessitate evidence-based ART adjustments to ensure virological suppression and reduce MTCT risk. Incorporating TDM, leveraging pharmacogenomic insights, and prioritizing maternal and neonatal safety are critical for personalized ART management. Further research into long-acting formulations and global guideline harmonization is needed to address disparities in care and improve outcomes for HIV-positive pregnant women.

Schlagwörter

Stichwörter der Autor:innen

HIV seropositivityantiretroviral therapydrug monitoringinfectious disease transmissionintegrase inhibitorsmetabolic side effects of drugs and substancespharmacokineticspregnancyprotease inhibitorsvertical

Autor:innen und Institutionen

  • School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia.
  • Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia.
  • Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), School of Medicine and Health Sciences, Universidad Del Rosario, Bogota 111221, Colombia.
  • Departamento de Salud Sexual y Reproductiva, Hospital Universitario Mayor Mederi, Bogota 111411, Colombia.

ORCID-Profile: Carlos-Alberto Calderon-Ospina

Förderung

  • Hospital Universitario Mayor—Méderi

Zitieren

APA

Briceño-Patiño, N., Prieto, M. C., Manrique, P., Calderon-Ospina, C. A., & Gómez, L. (2025). Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. Pharmaceutics, 17(7), 913. https://doi.org/10.3390/pharmaceutics17070913

Vancouver

Briceño-Patiño N, Prieto MC, Manrique P, Calderon-Ospina CA, Gómez L. Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women. Pharmaceutics. 2025;17(7):913. doi:10.3390/pharmaceutics17070913

BibTeX
@article{BriceoPatio2025,
  author = {Briceño-Patiño, Natalia and Prieto, María Camila and Manrique, Paula and Calderon-Ospina, Carlos-Alberto and Gómez, Leonardo},
  title = {Pharmacokinetic Adaptations in Pregnancy: Implications for Optimizing Antiretroviral Therapy in HIV-Positive Women},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {913},
  doi = {10.3390/pharmaceutics17070913}
}
Kostenlos starten →